IL-10 inhibits human T cell proliferation by downregulation of MHC class II expression, inhibiting the antigen-presenting capacity of monocytes and subsequently promotes glioma tumor growth [48, 52]. This evidence concerns the gene IL10 and central nervous system cancer.